Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas
Valle, G.; Carmignani, M.; Brunetti, L.; Volpe, A.R.
Journal of BUON Official Journal of the Balkan Union of Oncology 16(4): 787; Author Reply 787-8
2011
ISSN/ISBN: 1107-0625 PMID: 22331745 Document Number: 655476
Document emailed within 1 workday
Related Documents
Bernstein, M. 1997: Low-grade gliomas: in search of evidence-based treatment Clinical Neurosurgery 44: 315-330Gumusay, O.; Cetin, B.; Ozet, A.; Demirci, U.; Buyukberber, S.; Coskun, U.; Algin, E.; Uner, A.; Yildiz, R.; Kurt, G.; Benekli, M. 2014: Factors predicting recurrence in patients with grade IIi glial tumors: impact of adjuvant temozolomide on recurrence Journal of Buon: Official Journal of the Balkan Union of Oncology 19(4): 1035-1040
Safdari, H.; Mompeon, B.; Dubois, J.B.; Gros, C. 1985: Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report Surgical Neurology 24(5): 490-497
Sakarunchai, I.; Sangthong, R.; Phuenpathom, N.; Phukaoloun, M. 2013: Free survival time of recurrence and malignant transformation and associated factors in patients with supratentorial low-grade gliomas Journal of the Medical Association of Thailand 96(12): 1542-1549
Knerich, R.; Adinolfi, D.; Silvani, V.; Robustelli della Cuna, G.; Spanu, G.; Preti, P.; Rodriguez y Baena, R. 1984: Chemotherapy and immunotherapy of intracranial malignant gliomas Minerva Medica 75(21): 1333-1340
Izmaĭlov, T.R.; Pan'shin, G.A.; Misliukov, S.M.; Datsenko, P.V. 2013: Evaluation the effectiveness of radiation therapy high-grade gliomas based on the model of TDF (time-dose fractionation) Voprosy Onkologii 59(5): 629-635
Piyapittayanan, S.; Chawalparit, O.; Tritakarn, S.-O.; Witthiwej, T.; Sangruchi, T.; Nunta-Aree, S.; Sathornsumetee, S.; Itthimethin, P.; Komoltri, C. 2013: Value of diffusion tensor imaging in differentiating high-grade from low-grade gliomas Journal of the Medical Association of Thailand 96(6): 716-721
Cheson, B.D. 1991: Clinical trials referral resource. High-grade and low-grade gliomas Oncology 5(3): 87-89; 93
Segev, Y.; Ismiil, N.; McVey, R.; Covens, A. 2015: Surgical Stage i high-grade ovarian cancer: is adjuvant chemotherapy warranted? European Journal of Gynaecological Oncology 36(6): 633-636
Chawalparit, O.; Sangruchi, T.; Witthiwej, T.; Sathornsumetee, S.; Tritrakarn, S.; Piyapittayanan, S.; Chaicharoen, P.; Direksunthorn, T.; Charnchaowanish, P. 2013: Diagnostic performance of advanced MRi in differentiating high-grade from low-grade gliomas in a setting of routine service Journal of the Medical Association of Thailand 96(10): 1365-1373
Izmaĭlov, T.R.; Pan'shin, G.A.; Datsenko, P.V.; Zotov, V.K. 2012: The role of RPA classification in the treatment of high-grade gliomas Voprosy Onkologii 58(4): 521-526
Longree, L.; Focan, C.; Dallemagne, B.; Delforge, M.; Jehaes, C.; Malherbe, R.; Mazy, V.; Markiewicz, S.; Weerts, J.; Lombard, R. 1992: Tolerance of adjuvant treatment combining postoperative intraportal chemotherapy and a systemic treatment based on 5-fluorouracil in colorectal carcinoma with a histologically poor prognosis Acta Gastro-Enterologica Belgica 55(4): 341-349
Direksunthorn, T.; Chawalparit, O.; Sangruchi, T.; Witthiwej, T.; Tritrakarn, S.-O.; Piyapittayanan, S.; Charnchaowanish, P.; Pornpunyawut, P.; Sathornsumetee, S. 2013: Diagnostic performance of perfusion MRi in differentiating low-grade and high-grade gliomas: advanced MRi in glioma, a Siriraj project Journal of the Medical Association of Thailand 96(9): 1183-1190
Aldea, M.D.; Petrushev, B.; Soritau, O.; Tomuleasa, C.I.; Berindan-Neagoe, I.; Filip, A.G.; Chereches, G.; Cenariu, M.; Craciun, L.; Tatomir, C.; Florian, I.-S.; Crivii, C.B.; Kacso, G. 2014: Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells Journal of Buon: Official Journal of the Balkan Union of Oncology 19(2): 502-511
Cook, J.A.; Glass, J.; Lebovics, R.; Bobo, H.; Pass, H.; DeLaney, T.F.; Oldfield, E.H.; Mitchell, J.B.; Glatstein, E.; Goffman, T.E. 1992: Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine Cancer Research 52(3): 719-725
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456
Fidler, I.J.; Poste, G. 1985: The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy Seminars in Oncology 12(3): 207-221
Bacci, G.; Picci, P.; Gherlinzoni, F.; Van Horn, J.R.; Orlandi, M.; Normand, A.R.; Manfrini, M.; Pignatti, G.; Campanacci, M. 1986: Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(2): 140-143
Paccapelo, A.; Piana, C.; Rychlicki, F.; Recchioni, M.A.; Salvolini, U.; Ducati, A.; Bonsignori, M. 1998: Treatment of malignant gliomas: a new approach Tumori 84(5): 529-533
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104